Literature DB >> 19457986

The nucleocapsid region of human immunodeficiency virus type 1 Gag assists in the coordination of assembly and Gag processing: role for RNA-Gag binding in the early stages of assembly.

David E Ott1, Lori V Coren, Teresa Shatzer.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) Gag-RNA interactions are required for virus assembly. However, our prior study found that a defect in particle production exhibited by an HIV-1 proviral mutant with a severe deletion in the RNA-binding nucleocapsid (NC) region of Gag, NX, could be reversed by eliminating its protease activity. While our follow-up study indicated that a secondary RNA-binding site in Gag can also provide the required RNA-binding function, how protease activity inhibits NX virion production is still unclear. Therefore, we tested three possible mechanisms: NX virions are unstable and fall apart after budding; NX Gag assembly is slowed, allowing protease processing to start before particle formation; or the protease region within NX Gag-Pol becomes activated prematurely and processes the assembling Gag. We found that NX particles were as stable as wild-type virions. Furthermore, even a modest slowing of protease activity could rescue NX. Pulse-chase analysis revealed that the initial particle production by NC-deleted Gag was delayed compared to that of wild type Gag, but once started, the rate of production was similar, revealing a defect in the initiation of assembly. Wild-type Gag particle production was not eliminated or decreased in the presence of excess NX Gag-Pol, inconsistent with a premature activation of protease. Overall, these results indicate that the particle formation defect of NX is due to delayed initiation of assembly caused by the absence of NC in Gag, making it vulnerable to protease processing before budding can occur. Therefore, NC plays an important initiating role in Gag assembly.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19457986      PMCID: PMC2708646          DOI: 10.1128/JVI.00099-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

Review 1.  Human immunodeficiency virus type 1 assembly, release, and maturation.

Authors:  Catherine S Adamson; Eric O Freed
Journal:  Adv Pharmacol       Date:  2007

2.  Imaging the biogenesis of individual HIV-1 virions in live cells.

Authors:  Nolwenn Jouvenet; Paul D Bieniasz; Sanford M Simon
Journal:  Nature       Date:  2008-05-25       Impact factor: 49.962

3.  The role of nucleocapsid of HIV-1 in virus assembly.

Authors:  L Dawson; X F Yu
Journal:  Virology       Date:  1998-11-10       Impact factor: 3.616

4.  Heterologous late-domain sequences have various abilities to promote budding of human immunodeficiency virus type 1.

Authors:  David E Ott; Lori V Coren; Tracy D Gagliardi; Kunio Nagashima
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Redundant roles for nucleocapsid and matrix RNA-binding sequences in human immunodeficiency virus type 1 assembly.

Authors:  David E Ott; Lori V Coren; Tracy D Gagliardi
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

6.  Dynamic fluorescent imaging of human immunodeficiency virus type 1 gag in live cells by biarsenical labeling.

Authors:  Lynnie Rudner; Sascha Nydegger; Lori V Coren; Kunio Nagashima; Markus Thali; David E Ott
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein.

Authors:  M T Burniston; A Cimarelli; J Colgan; S P Curtis; J Luban
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

8.  In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain.

Authors:  S Campbell; A Rein
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  Functional complementation of nucleocapsid and late domain PTAP mutants of human immunodeficiency virus type 1 during replication.

Authors:  Olga A Nikolaitchik; Robert J Gorelick; Maria G Leavitt; Vinay K Pathak; Wei-Shau Hu
Journal:  Virology       Date:  2008-03-19       Impact factor: 3.616

10.  HIV-1 matrix protein repositioning in nucleocapsid region fails to confer virus-like particle assembly.

Authors:  Ching-Yuan Chang; Yu-Fen Chang; Shiu-Mei Wang; Ying-Tzu Tseng; Kuo-Jung Huang; Chin-Tien Wang
Journal:  Virology       Date:  2008-06-12       Impact factor: 3.616

View more
  14 in total

Review 1.  Properties and functions of the nucleocapsid protein in virus assembly.

Authors:  Delphine Muriaux; Jean-Luc Darlix
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

Review 2.  The choreography of HIV-1 proteolytic processing and virion assembly.

Authors:  Sook-Kyung Lee; Marc Potempa; Ronald Swanstrom
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

3.  The HIV-1 nucleocapsid protein recruits negatively charged lipids to ensure its optimal binding to lipid membranes.

Authors:  Noémie Kempf; Viktoriia Postupalenko; Saurabh Bora; Pascal Didier; Youri Arntz; Hugues de Rocquigny; Yves Mély
Journal:  J Virol       Date:  2014-11-19       Impact factor: 5.103

4.  A single amino acid substitution in HIV-1 reverse transcriptase significantly reduces virion release.

Authors:  Chien-Cheng Chiang; Shiu-Mei Wang; Yen-Yu Pan; Kuo-Jung Huang; Chin-Tien Wang
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

5.  Retrovirus-specific differences in matrix and nucleocapsid protein-nucleic acid interactions: implications for genomic RNA packaging.

Authors:  Meng Sun; Iwen F Grigsby; Robert J Gorelick; Louis M Mansky; Karin Musier-Forsyth
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

Review 6.  Retroviral matrix and lipids, the intimate interaction.

Authors:  Elise Hamard-Peron; Delphine Muriaux
Journal:  Retrovirology       Date:  2011-03-07       Impact factor: 4.602

7.  HIV-1 matrix domain removal ameliorates virus assembly and processing defects incurred by positive nucleocapsid charge elimination.

Authors:  Li-Jung Ko; Fu-Hsien Yu; Kuo-Jung Huang; Chin-Tien Wang
Journal:  FEBS Open Bio       Date:  2015-04-09       Impact factor: 2.693

8.  Extreme genetic fragility of the HIV-1 capsid.

Authors:  Suzannah J Rihn; Sam J Wilson; Nick J Loman; Mudathir Alim; Saskia E Bakker; David Bhella; Robert J Gifford; Frazer J Rixon; Paul D Bieniasz
Journal:  PLoS Pathog       Date:  2013-06-20       Impact factor: 6.823

Review 9.  The roles of lipids and nucleic acids in HIV-1 assembly.

Authors:  Ayna Alfadhli; Eric Barklis
Journal:  Front Microbiol       Date:  2014-05-28       Impact factor: 5.640

10.  HIV-1 nucleocapsid and ESCRT-component Tsg101 interplay prevents HIV from turning into a DNA-containing virus.

Authors:  Célia Chamontin; Patrice Rassam; Mireia Ferrer; Pierre-Jean Racine; Aymeric Neyret; Sébastien Lainé; Pierre-Emmanuel Milhiet; Marylène Mougel
Journal:  Nucleic Acids Res       Date:  2014-12-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.